VTRS

Market

Viatris Inc [VTRS] moved down -0.42: Why It’s Important

Viatris Inc [NASDAQ: VTRS] loss -0.42% on the last trading session, reaching $11.75 price per share at the time. The company report on April 1, 2024 at 7:14 AM that Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner

Industry

Viatris Inc [VTRS] moved down -1.94: Why It’s Important

Viatris Inc [NASDAQ: VTRS] price plunged by -1.94 percent to reach at -$0.23. The company report on February 28, 2024 at 6:30 AM that Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance. Meets 2023 Guidance for Total Revenues, Adjusted EBITDA